Strive Health is a leading kidney care provider, serving over 100,000 patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) across 30 states. The company partners with 600+ nephrology providers, as well as commercial/Medicare Advantage payers, Medicare, and health systems through flexible payment arrangements. Strive's tech-enabled care model has demonstrated 20% lower total cost of care and 42% fewer hospitalizations compared to FFS Medicare.
Strive was co-founded in 2018 by CEO Chris Riopelle, who brings deep expertise in value-based care delivery models from his prior work at Evolent Health and Oxeon Partners. Since launching, Strive has rapidly scaled to 550 employees managing $2.5 billion in annual medical spend. The company raised $166 million in Series C funding led by NEA in May 2023 to expand market presence, invest in technology/analytics, and scale its high-touch clinical model in partnership with nephrologists and payors.
By joining Strive's mission-driven team of "Kidney Heroes," employees have the opportunity to transform care for the 37 million U.S. adults suffering from kidney disease. With a strong growth trajectory and backing from top healthcare investors like NEA, Venrock, and CVS Health Ventures, Strive is poised to become the premier value-based kidney care platform.
2018
Founded
250-500
Employees
Series C
Stage
$1B-$3B
Latest Valuation
$200-400M
Total Funding
May 05 2023
Last Fundraise
Why is the rating
Top Previous Employers
CareMore Health
DaVita Kidney Care
Evolent Health
Fresenius Medical Care
Optum
Investors
Redpoint Ventures
Stripe, Snowflake, Twilio